16.39CAD-1.50%Mkt Cap: 303.08M $P/E: 9.701d ago
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and r…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap303.08M $
Enterprise Value274.85M $
Revenue (TTM)37.10M $
Gross Profit29.44M $
Net Income (TTM)19.90M $
Revenue/Share1.456 USD
Last Price16.39 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)9.70
P/E (Forward)14.38
PEG—
EV/EBITDA14.06
EV/Revenue7.41
P/S8.17
P/B2.22
EPS (TTM)1.69
EPS (Forward)1.14
52W Range
11.9851% of range20.56
52W High20.56 CAD
52W Low11.98 CAD
Profitability
Gross Margin80.12%
Oper. Margin44.74%
EBITDA Margin52.70%
Profit Margin54.17%
ROE21.65%
ROA17.46%
Growth
Revenue Growth4.00%
Earnings Growth140.00%
Cash Flow & Leverage
Operating CF21.65M $
CapEx (TTM)146.38K $
FCF Margin43.72%
FCF Yield5.35%
Net Debt-4.36M $
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.04
Current Ratio1.25
Quick Ratio0.79
Book Value/Sh7.398 CAD
Cash/Share0.2740 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.64 CAD
Upside (mean)+25.9%
Target Range17.00 CAD – 22.25 CAD
CAD17.00+25.9% to meanCAD22.25
# Analysts4
Ownership
Shares Out.25.39M
Float13.66M
Insiders42.36%
Institutions1.31%
Short Interest
Short Ratio4.5d
Short % Out.0.28%
Shares Short66.78K
Short (prev mo.)78.88K
Technical
SMA 5016.87 (-2.8%)
SMA 20015.83 (+3.5%)
Beta0.48
S&P 52W Chg19.63%
Avg Vol (30d)15.19K
Avg Vol (10d)13.36K
Technical Indicators
RSI (14)42.7
MACD0.0043
MACD Signal0.0189
MACD Hist.-0.0146
BB Upper17.43 CAD
BB Middle16.70 CAD
BB Lower15.97 CAD
BB Width8.68%
ATR (14)0.4137 CAD
Vol Ratio (20d)1.44x